Bajaj Healthcare
manufactures caffeine and theobromine pharmaceutical-grade API supplying European and global pharma formulation markets, the Indian API-production node of the methylxanthine supply chain.
- Country
- India
- Ticker
- BSE:542920
Commercial
Caffeine & theobromine pharma API; BSE: 542920; founded 1993
in
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| specialty-fine-chem | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaefsa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biosynthetic theobromine | specialty-fine-chem | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.